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Leonardo da Silva Prestes4 and Marcelo Fouad Rabahi1,2Abstract
Background: Depression is a common comorbidity among patients with Chronic Obstructive Pulmonary Disease
(COPD) and has a significant impact on the course of the disease. The aim of this study is to determine association
between COPD Assessment Test (CAT) and major depression among clinically stable out-patient COPD subjects with
mild hypoxemia.
Methods: Case–control study. Cases were 30 patients with major depression and controls were 30 patients without
depression. Major depression was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders
criteria by a psychiatric evaluation. All possible predictive variables were included in a multivariate logistic
regression model to assess the association between major depression and each independent variable, while
controlling for the sleep parameters.
Results: CAT score >20 was associated with major depression (OR 7.88; 95% CI 1.96 - 31.7; p = 0.004).
Conclusion: CAT score >20 was associated with major depression, suggesting CAT as a predictor variable of major
depression among COPD patients with mild hypoxemia, and indicating that an additional specific evaluation for the
presence of major depression should be done.Background
Chronic Obstructive Pulmonary Disease (COPD) is a
medical condition with multiple comorbidities [1]. One of
the most common is depression that occurs in 10 to 42%
of persons with COPD and is associated with low quality
of life [2,3]. Depression is associated with increased fre-
quency of hospital admissions, prolonged length of stay,
increased number of consultations, low compliance with
medical treatment and premature death [4-6].
The etiology of depression in COPD is unknown. It is
supposed that a genetic predisposition is more likely to
exist, followed by the environmental assaults imposed by* Correspondence: joselaertejr@gmail.com
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unless otherwise stated.the respiratory illness itself and the direct neuropsychi-
atric effects of chronic respiratory disease [7]. Little is
known regarding variables associated to COPD that may
predict depression [8-10].
It was hypothesized that COPD patients with symptoms
of depression could report higher CAT scores (because of
worse health status) compared to those without depres-
sion, as CAT scores are strongly positively correlated with
St George’s Respiratory Questionnaire (SGRQ) scores
[11]. Several studies addressed this issue, [11-16] and
found that CAT scores are significantly associated with
the presence of symptoms of depression measured by
Hospital Anxiety and Depression Scale (HADS) or pa-
tient health questionnaire-9 (PHQ-9) scores, but to the
best of our knowledge, there is no data evaluating the
association between CAT scores and major depression
diagnosed by a psychiatric evaluation. The associationtral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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once these mentioned depression scores may indicate
symptoms suggestive of depression, but not necessarily
the diagnosis of a depression disease [17]. The aim of
the present study is to determine the association between
CAT score and major depression diagnosed according
to the Diagnostic and Statistical Manual of Mental Dis-
orders (DSM IV) criteria by a psychiatric evaluation






The study was conducted at the Research Center of
CLARE Outpatient Chest Clinic of Goiania (Goias, Brazil),
a city localized in the middle-west of Brazil, with 1,393,575
habitants and an estimated prevalence of 16% COPD
patients [18].
Subject selection, data collection and definitions
Clinically stable COPD patients aged 40 years and over
admitted to the Research Center of CLARE Out-patient
Chest Clinic between April 1st and September 31st,
2013 were considered eligible and invited to take part
of the study. After signing the informed consent, an in-
strument of data collection was applied, and a digital
oximetry was performed to select only mild daytime
hypoxemic patients. Subjects with oxygen saturation
level < 90% (moderate to severe daytime hypoxemic pa-
tients), or ≥95% (normal oximetry), or with a FEV1/
FVC >70 (not COPD by GOLD criteria) were excluded.
They subsequently performed clinical evaluation, psychi-
atric evaluation, spirometry, polysomnography, echocardi-
ography, arterial blood gas analysis, chest radiograph and
validated questionnaires of dyspnea [19], health impair-
ment (COPD Assessment Test - CAT) [20], socioeco-
nomic status [21], and depression (Beck Depression
Inventory - BDI, second revision) [22]. Exclusion cri-
teria of the study were pregnancy, recent myocardial in-
farction (less than three months), asthma previous
medical history or any other concomitant pulmonary
disease, use of drugs associated with depression (lipo-
philic β-blockers, anabolic steroids, digoxin, levodopa,
benzodiazepines and pemoline), history of cancer diag-
nosis, presence of renal insufficiency or performing dia-
lysis, presence of insulin dependent diabetes, presence
of resting PaO2 < 60 mmHg, presence of radiographic
evidence of any significant abnormality not attributable
to COPD, inability to understand or complete all ques-
tionnaires, tests and interviews. Clinical stability was
defined as the absence of exacerbation [23] for theprevious four weeks. Smoking status was categorized as
current smokers, ex-smokers and never-smokers [24].
Major depression was diagnosed according to the Diag-
nostic and Statistical Manual of Mental Disorders, 4th
edition (DSM IV) criteria by a psychiatric evaluation
and was measured by the Beck Depression Inventory
(BDI), second revision [22]. COPD subjects were classi-
fied using the GOLD criteria (chronic respiratory symp-
toms, history of exposure to risk factors for the disease,
and post-bronchodilator FEV1/FVC ratio <70 in the
spirometric evaluation) [25]. Nocturnal hypoxemia was
defined as an oxygen saturation level <90% for at least
5 minutes, with a nadir oxygen saturation level of ≤85%,
and was considered significant when occurring at least
30% of the total sleep time [26-29]. The polysomnography
was performed using Alice 5 Diagnostic Sleep System
(Murrysville, PA, USA) in a sleep laboratory. Recordings
were interpreted and sleep stages were determined ac-
cording to recommendations provided by the American
Academy of Sleep Medicine [30].
Thirty COPD patients with depression (cases) and
thirty COPD patients without depression (controls)
paired by demographic characteristics were enrolled in
this study.
Sample size
n order to calculate sample size, the t-test was used to
determine whether the COPD Assessment Test differs
significantly from the COPD group with and without
major depression. A previous study reported the mean
and standard deviation of the CAT of out-patients
COPD subjects: 24.6 ± 6.6 [31]. We intended to be able
to detect a difference of 20% or more in mean CAT be-
tween groups. We calculated that would be required 28
COPD subjects in each group at a α (two-sided) = 0.05
and power = 0.80. Assuming possible losses, we chose
to include two more individuals in each group totaling
60 patients.
Statistical analysis
The results were analyzed with Stata program version
11.0 (StataCorp, Texas, USA), using p <0.05. Variables
were described using proportions, mean and standard
deviation, or median and IQR. Student’s t-test was used
to compare two means, Mann–Whitney test was used to
compare two medians, and the chi-square test or Fisher’s
exact test was used for dichotomous variables. Correl-
ation was conducted to assess the strength of linear rela-
tionships between numerical variables The unadjusted
odds ratio (OR) of the association between predict vari-
ables and the outcome (major depression) variable with
95% confidence interval (CI) was calculated. All possible
predictive variables were included in a multivariate logis-
tic regression model to assess the association between
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controlling for the sleep parameters. The cutoff value of
the CAT as a depression predictor was calculated by use
of a receiver operating characteristic (ROC) curve.
Ethical aspects
This study was conducted according to good clinical
practices (ICH – G6) and was approved by the Ethics
Committee of the Hospital Geral of Goiania under num-
ber 198.344/2013.
Results
Over a 6 month period, 230 patients with COPD were
admitted in the Outpatient Chest Clinic and assessed
for eligibility. From them, 66 patients (28.7%) were notFigure 1 Study design and subjects.included due to domiciliary oxygen therapy, decline to
participate or FEV1/FVC ratio > 70. From the 164 in-
cluded patients, 93 (56.7%) were excluded due to oxygen
saturation ≥95% or <90%, 4 (2.4%) due to radiologic
evidence of significant abnormalities not attributable to
COPD and 3 (1.8%) resting PaO2 < 60 mmHg, and 4
(2.4%) due to use of drugs associated with depression
(Figure 1).
The paired variables and variables not paired of the
study population are presented on Tables 1 and 2, re-
spectively. The univariate logistic regression analysis
showed that only the BDI, OR: 1.24, 95% CI 1.12-1.37,
p < 0.0001; CAT, OR:1.13, 95% CI 1.04-1.24, p = 0.005;
the proportion of TST of sleep stage II, OR:1.06, 95%
CI 1.01-1.12, p = 0.02; and the proportion of TST of
Table 1 Paired variables among cases and controls
All subjects Cases Control group
n = 60 n = 30 n = 30 p
Age, years 69.7 ± 9.0 68.8 ± 10.2 70.5 ± 7.8 0.46
Education (years) 4 (5)† 4 (1)† 4 (12)† 0.80
Socioeconomic score 17 (9)† 16 (6)† 19 (9)† 0.07
Data are presented as mean ± SD, n (%) or median (interquartile range)†. The
Socioeconomic score was assessed by the questionnaire of the Brazilian
Association of Research Companies (range 0–40).
Silva Júnior et al. BMC Pulmonary Medicine 2014, 14:186 Page 4 of 7
http://www.biomedcentral.com/1471-2466/14/186REM sleep stage OR:0.92, 95% CI 0.85-0.99, p = 0.03 pre-
dicted major depression. All other clinical (exacerbation
frequency in the year prior to enrollment, gender, smok-
ing), spirometric, gasometric and sleep variables did not
predict major depression. After adjusting for TST of sleepTable 2 Variables not paired among cases and controls
All subjects
n = 60
Male gender, n (%) 36 (60)
BMI, kg/m2 24.9 ± 5.0
Neck circumference, cm 36.4 ± 4.8
Systolic blood pressure, mmHg 120 (20)†
Diastolic blood pressure, mmHg 74.5 ± 8.5
Hypertension treatment, n (%) 34 (56.7)
Smoking intensity (pack years) 48.5 (33)†
Smoking status Current smoker 15 (25)
n (%) Former smoker 40 (66.7)
Never smoked 5 (8.3)
COPD Classification GOLD A 6 (10)
n (%) GOLD B 8 (13.3)
GOLD C 1 (1.7)
GOLD D 45 (75)
Pos-Bd FVC (liters) 2.52 ± 0.8
Pos-Bd FEV1 (liters) 1.31 ± 0.6
Pos-Bd FEV1/FVC (%) 75.5 ± 18.4
PaO2, mmHg 71.7 ± 8.9
PaCO2, mmHg 34.9 ± 5.0
Oxygen saturation, gasometry (%) 93.8 ± 2.0
LV ejection fraction (%) 69.5 (8)†
LV systolic dysfunction, n (%) 2 (3.3)
LV diastolic dysfunction, n (%) 43 (71.7)
Pulmonary hypertension , n (%) 3 (5)
Normal sPAP, n (%) 28 (46.7)
Undetermined sPAP, n (%) 29 (48.3)
Beck Depression Inventory (0–63) 15.4 ± 10.4
COPD Assessment Test (0–40) 17.1 ± 7.1
Data are presented as mean ± SD, n (%) or median (interquartile range)†. The Socio
of Research Companies (range 0–40). LV systolic dysfunction definition: left ventricu
Pulmonary hypertension: sPAP > 40. Undetermined sPAP: patients without tricuspidstage II and TST of REM sleep stage, multiple logistic
regression analysis revealed that only the BDI and CAT
were independent predictors of major depression (Table 3).
The CAT score correlated well with the BDI score (r =
0.56); p < 0.00001. In order to assess if CAT would signifi-
cantly correlate just in the case group, we performed the
same analysis in the control group and also found a statis-
tically significant correlation (r = 0.46; p = 0.01). A linear
regression showed that CAT significantly predicted the
BDI score (Figure 2). Comparing the sensibility, specifi-
city, positive and negative predictive value, and area
under the ROC curve of each CAT cutoff, the best
combination of positive predictive value and a ROC
curve area without a significant loss in sensibility was
CAT >20 (OR 7.88; 95% CI 1.96 - 31.7; p = 0.004).Cases Control group
n = 30 n = 30 p
15 (50) 21 (70) 0.11
24.5 ± 4.6 25.3 ± 5.5 0.54
35.6 ± 4.8 37.3 ± 4.7 0.22
125 (20)† 120 (20)† 0.61
74.3 ± 6.3 74.7 ± 10.4 0.88
18 (60) 16 (53.3) 0.60
46.5 (38.4)† 48.5 (32)† 0.83
9 (30) 6 (20)
17 (56.7) 23 (76.7) 0.21
4 (13.3) 1 (3.3)
3 (10) 3 (10) 0.09
7 (23.3) 1 (3.3)
0 (0) 1 (3.3)
20 (66.7) 25 (83.3)
2.46 ± 0.8 2.57 ± 0.9 0.59
1.33 ± 0.6 1.29 ± 0.6 0.78
53 ± 12.1 49.8 ± 12.1 0.31
71.3 ± 8.0 72.1 ± 9.7 0.73
34.1 ± 5.8 35.7 ± 4.2 0.24
93.9 ± 2.1 93.7 ± 1.9 0.71
70 (10)† 69 (6)† 0.93
2 (6.7) 0 (0) 0.49
22 (73.3) 21 (70) 0.77
1 (3.3) 2 (6.7) 0.70
13 (43.3) 15 (50)
16 (53.4) 13 (43.3)
22.3 ± 9.6 8.6 ± 5.4 <0.0001*
19.8 ± 7.3 14.3 ± 5.8 0.002*
economic score was assessed by the questionnaire of the Brazilian Association
lar ejection fraction (LVEF) ≤40%. sPAP: systolic pulmonary artery pressure.
regurgitant flow.
Table 3 Multivariate logistic regression analysis assessing
predictive value of Beck Depression Inventory or COPD
Assessment Test adjusting for sleep parameters
Variables Adjusted OR CI 95% p
Beck Depression Inventory 1.24 1.11 - 1.39 <0.0001*
Sleep stage II (% of TST) 1.07 0.99 - 1.16 0.08
REM Sleep stage (% of TST) 1.01 0.89 - 1.16 0.22
COPD Assessment Test 1.17 1.06 - 1.30 0.002*
Sleep stage II (% of TST) 1.07 1.00 - 1.15 0.06
REM Sleep stage (% of TST) 0.97 0.87 - 1.07 0.51
CI: confidence interval. OR: odds ratio. TST: total sleep time. *Statistically
significant difference.
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using cutoffs of BDI II(≥14) and CAT(>20) we found
that BDI-II had a specificity of 80% (95% CI 61.4%-
92.3%); sensitivity of 80% (95% CI 61.4%-92.3%); positive
and negative predictive values of 80% (95% CI 65.7%-
89.3%), and 80% (95% CI 65.7%-89.3%), respectively; area
under the ROC curve 0.80 (95% CI 0.70-0.90). CAT > 20
had a specificity of 90% (95% CI 73.5%-97.9%); sensitivity
of 46.7% (95% CI 28.3%-65.7%); positive and negative
predictive values of 82.4% (95% CI 59.9%-87.2%), and
61% (95% CI 51.9%-61.4%), respectively; and area under
the ROC curve 0.65 (95% CI 0.54-0.76).
Discussion
Our findings showed that CAT may be a predictor vari-
able of major depression among COPD patients with
mild hypoxemia. As CAT score is routinely used among
COPD patients, value above 20 may be used as a screening
test for an additional evaluation with a specific depressionFigure 2 Linear regression of Beck Depression Inventory and COPD Aquestionnaire. Although it is not the first time that CAT is
associated with depression, it is the first manuscript dem-
onstrating the association between CAT and major depres-
sion diagnosed by DSM IV. The majority of the studies
that reported CAT-depression association [11,13-16] were
not designed specifically to investigate this issue, but ad-
dressing other primary objectives found weak to moderate
correlations as a secondary finding: Hilmarsen et al.
[11], using the Hospital Anxiety and Depression Scale
(HADS), assessing COPD patients with symptoms of
anxiety and/or depression reported a worse disease-
specific health status assessed by CAT in comparison with
patients without these symptoms (r = 0.35). Miyazaki
et al., studying a COPD cohort designed to prospectively
investigate the management of COPD comorbidities,
found that the presence of depression (HADS-D ≥ 11) was
significantly associated with increased scores of CAT (r2 =
0.15) [13]. Different studies found weak correlations (0.30
to 0.39) between CAT scores and depression scores mea-
sured by HADS [14-16]. A study designed to investigate
the association between CAT and depression specifically
among COPD patients found a good correlation (r = 0.63)
between CAT ≥21 and depression as diagnosed by the pa-
tient health questionnaire-9 (PHQ-9) [12].
The ability of CAT to be a predictor variable of de-
pression may be due to the capture the health status im-
pairment of the COPD patient, as loss of functionality is
a strong mediator of the development of depression in
chronic illness, with an attributable risk measured at
34% [7]. This health status impairment that includes de-
creased mobility, inability to carry out prior occupational
activities and decreased ability to participate in previ-
ously enjoyed recreational activities could act as a triggerssessment Test scores.
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One alternate view could explain the results in the other
way around: the depressive subject could make a poor
self evaluation of his health status impairment causing
the CAT score to increase according with the depression
score. Based on this, we assessed the CAT/BDI correl-
ation among cases and controls in order to verify if CAT
would significantly correlate just in the case group. As it
was shown, there was also correlation on control group,
suggesting that health status impairment could be a me-
diator of depression in this group of patients.
The increase of the proportion of TST of sleep stage II
and a reduction of the proportion of TST of REM sleep
stage findings of this study are in concordance with
sleep findings of older adults with depression, as they in-
clude decreased sleep efficiency, poor sleep continuity,
increases in stage I and II sleep [32] and a reduction on
REM sleep in the last 1/3 of the night [33].
Although there are several screening tools available
to identify depressive patients (Beck Depression Inven-
tory, second revision, Center for Epidemiologic Studies
Depression Scale (CES-D), Geriatric Depression Scale
(GDS), Hospital Anxiety and Depression Scale (HADS),
Patient Health Questionnaire-9 (PHQ-9)) [17], none of
them are currently used in the level of the primary care
setting [12,34]. CAT is a COPD-specific health status
measure [20] and although it has already been demon-
strated that it correlates with depression symptoms
[11-16], we showed that it could not replace a specific
case finding tool [22] to identify major depression.
However, our findings suggests that a CAT >20 was
strongly associated with major depression (OR 7.88;
95% CI 1.96 - 31.7) and could be an important tool for
depression screening purposes among COPD patients
with mild hypoxemia.
Our study had several limitations. We used the Stu-
dent’s t test and a continuous outcome variable to esti-
mate an appropriate number of subjects for this study
design. It is known that this procedure permits a smaller
sample size for a given power, but as small samples sizes
are more prone to variability, this may lead to concealed
bias. The choice of a dichotomous outcome, instead of a
continuous one, would increase the sample size estima-
tion and reduce variability. However, as we use a differ-
ent methodology to establish the case status and our
results are in concordance with others, our relatively
small sample size may have not been a problem. We de-
signed the study to address CAT as a predictor of major
depression in a subgroup of COPD patients with hypox-
emia. However, we exclude moderate and severe hypoxic
patients in order to address in a group of hypoxemic
subjects with less compromised functional status. Fur-
thermore, the inclusion of moderate and severe hypoxic
patients would increase the mean CAT score in thecontrol group reducing the power of the sample. Conse-
quently, a selection bias was introduced because patients
of the daily ambulatory practice have different levels of
hypoxemia, varying from the normoxemia to severe
hypoxemia.
Conclusions
In our sample the CAT score >20 was a predictor vari-
able of major depression among COPD patients with
mild hypoxemia, suggesting the need of an additional in-
vestigation with a specific depression questionnaire. If the
evaluation by a specific instrument also indicates depres-
sion, appropriate treatment for depression and/or a refer-
ral to psychiatric assessment should be done.
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